1 active trials 0 recruiting 1 disease areas 2 changes in 30 days
| Phase 2 | 1 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 2 | ||||
| NCT05874193 | A Collaborative Community Effort Using Belantamab Mafodotin in Relapsed/Refractory Myeloma | Relapsed/Refractory Multiple Myeloma | Not Yet Recruiting | 2026-08-31 |
Multiple Myeloma (1)